Merck to Cut Thousands of Jobs in Cost-Cutting Move

by Christopher Freeburn | October 1, 2013 11:58 am

MerckPromo[1]Shares of pharmaceutical giant Merck (MRK[2]) climbed more than 2% in Tuesday morning trading after the company announced a round of layoffs[3].

The company issued a statement saying that it will slash 8,500 jobs across its research and development operations. The job losses are part of a move to trim costs by $2.5 billion by 2015. Merck says that it will achieve up to $1 billion in savings next year, USA TODAY notes.

The drug-maker had previously announced plans to cut its payroll by 7,500 workers. The new job cuts will come in addition to those.

Under a new research and development chief, Merck is attempting to streamline operations and boost its pipeline of new drugs.

In July, the U.S. Food and Drug Administration declined to approve 15 milligram doses[4] for Merck’s suvorexant sleeping pill, citing possible safety concerns.

Earlier this year, the company teamed with Pfizer (PFE)[5] to develop a new diabetes drug[6].

  1. [Image]:
  2. MRK:
  3. after the company announced a round of layoffs:
  4. declined to approve 15 milligram doses:
  5. PFE):
  6. develop a new diabetes drug:

Source URL:
Short URL: